Synthetic biology represents a revolutionary discipline that applies engineering principles to biology, aiming to develop cells into sophisticated micro-factories capable of producing essential materials. With the potential to spearhead advancements across numerous industries—including medicine,
In a groundbreaking development, QIMR Berghofer has made significant strides in combating severe viral infections in immunocompromised patients through their pioneering cell therapy. This innovative treatment has proven effective in 46 out of 71 patients, resulting in a notable 65% success rate.
Heart disease remains a leading cause of mortality worldwide, with heart failure accounting for 13 percent of global deaths. The inability of the human heart to regenerate lost muscle cells after birth has driven the exploration of cell-based therapies. Over the past two decades, significant
Beckman Coulter Life Sciences, a subsidiary of Danaher Corporation, has announced the launch of the Cydem VT Automated Clone Screening System, an innovative platform designed to transform the world of drug discovery through advanced laboratory automation and innovation. This groundbreaking
Recent findings have shed light on the pivotal role of fibroblastic reticular cells (FRCs) in enhancing the immune response within lung cancer tumors, particularly non-small cell lung cancer (NSCLC). These specialized cells create environments that bolster T-cell activity, potentiating anti-tumor
Roche is making a bold move in the field of allogeneic cell therapy with its recent acquisition of Poseida Therapeutics, a San Diego-based biotech firm. This $1 billion upfront deal underscores Roche's commitment to expanding its portfolio in cell and gene therapies, particularly targeting blood
